FOR US HEALTH CARE PROFESSIONALS ONLY
Prescribing Information
APOKYN® (apomorphine hydrochloride injection)GOCOVRI® (amantadine) extended-release capsulesMYOBLOC® (rimabotulinumtoxinB) injectionOXTELLAR XR® (oxcarbazepine) extended-release tabletsQELBREE® (viloxazine extended-release capsules)TROKENDI XR® (topiramate) extended-release capsulesXADAGO® (safinamide) tabletsONAPGOTM (apomorphine hydrochloride), for subcutaneous infusion
Adverse Event/Product Complaint
To report a suspected adverse event or product complaint, contact us at 1-866-398-0833 or email medinfo.supernus@apceris.com.
Connect With Us
Supernus Medical Affairs Logo
FOR US HEALTH CARE PROFESSIONALS ONLY
Supernus Medical Affairs LogoMenu Toggle
FIND AN MSLArrow RightSUBMIT AN INQUIRYArrow Right

UPCOMING EVENTS

We look forward to seeing you in person at the next congress.

VIEW ALL CONGRESS POSTERSArrow Right

THERAPEUTIC AREAS

Discover our advancements in psychiatry and neurology.

psychiatry icon

PSYCHIATRY

Attention-Deficit/ Hyperactivity Disorder (ADHD)

EXPLORE ADHDArrow Right
neurology icon

NEUROLOGY

Parkinson’s Disease (PD)

EXPLORE PDArrow Right

PRODUCT PIPELINE

pipeline icon

Novel treatments for CNS disorders

EXPLORE PIPELINEArrow RightEXPLORE PIPELINEArrow Right

CONNECT WITH US

product inquiry icon

Submit a Product Inquiry

Our Medical Information team is available to answer your questions.

SUBMIT AN INQUIRYArrow Right
grant request icon

Submit a Grant Request

Register on our Grants Portal to submit your grant proposals.

SUBMIT A REQUESTArrow Right
find msl icon

Find a Medical Science Liaison

Looking for an MSL in your region?

FIND AN MSLArrow Right
Supernus Logo
Research & DevelopmentConnect With UsTerms of UsePrivacy PolicyCookie Policy

This site is intended for US health care professionals.
The content on this website is intended for informational purposes only and should not be used as the sole basis for patient care decisions.

Supernus Pharmaceuticals, Inc.
9715 Key West Avenue, Rockville, MD 20850
(301) 838-2500
info@supernus.com

© 2025 Supernus Pharmaceuticals, Inc.